Submitted by Anonymous (not verified) on 16 October 2023 - 15:03
Human medicines European public assessment report (EPAR): Atectura Breezhaler, indacaterol,mometasone, Asthma, Date of authorisation: 30/05/2020, Revision: 9, Status: Authorised
Source: